RANBAXY MALAYSIA SON BHD

RANBAXY MALAYSIA SDN BHD is a Manufacturer (Factory).

Company Introduction:

RANBAXY MALAYSIA SDN BHD was the Malaysian subsidiary of Ranbaxy Laboratories Limited, a formerly prominent Indian multinational pharmaceutical company. It operated as a pharmaceutical manufacturing facility, involved in the production, packaging, and distribution of a wide range of generic medicines within Malaysia. The company's primary focus was on manufacturing pharmaceutical formulations for various therapeutic segments, contributing to the local healthcare market. Following the global acquisition of Ranbaxy Laboratories Limited by Sun Pharmaceutical Industries Ltd., RANBAXY MALAYSIA SDN BHD would have been integrated into Sun Pharma's regional operations. Its core business activities firmly established it as a manufacturing entity within the Malaysian pharmaceutical industry.

Based on available information, RANBAXY MALAYSIA SON BHD, which is now part of Sun Pharma, manufactures and/or markets a range of pharmaceutical products. These typically include:

* Generic medications

* Active Pharmaceutical Ingredients (APIs)

* Various therapeutic drugs spanning multiple categories (e.g., cardiovascular, anti-infectives, pain management, etc.)

Please note that the specific product portfolio may have evolved since Ranbaxy's acquisition by Sun Pharma. For the most up-to-date details, it is best to consult Sun Pharma's official website or contact them directly.